Published in Br Med J on June 04, 1977
Circulating immune complexes and symptoms in Hodgkin's disease. Lancet (1976) 1.53
Nephrosis of Hodgkin disease. An immune complex-induced lesion. Arch Intern Med (1973) 1.08
Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma. Lancet (1985) 2.51
Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime. Br J Cancer (1971) 2.08
Heredopathia atactica polyneuritiformis: Refsum's disease. Acta Neurol Scand (1985) 2.03
Liposarcoma. A review of 60 cases. Br J Cancer (1970) 1.80
Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer. Br J Urol (1987) 1.66
Recurrent Cancer of Head and Neck. Br Med J (1962) 1.63
Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange. Lancet (1979) 1.53
Interim results of treatment of breast cancer with breast conservation for all patients. Surgery (1987) 1.51
Preliminary clinical assessment of I.C.R.F. 159 in acute leukaemia and lymphosarcoma. Br Med J (1969) 1.46
Radiotherapy and conservative surgery in the management of musculo-aponeurotic fibromatosis. Int J Radiat Oncol Biol Phys (1988) 1.45
Cancer and HIV infection. Clin Oncol (R Coll Radiol) (1997) 1.41
What is the optimal therapy of brain metastases? Clin Oncol (R Coll Radiol) (2001) 1.40
Radiotherapy combined with chemotherapy in the treatment of selected cases. I. Sarcomata arising in the lower limbs II. Some head and neck tumours. Br J Radiol (1967) 1.37
Radiotherapy for massive haemoptysis from an aspergilloma. Thorax (1980) 1.32
Are some women's breast cancers androgen dependent? Lancet (1973) 1.21
The local treatment of breast cancer. Practitioner (1980) 1.20
Development of in vitro assays for the detection of botulinum toxins in foods. FEMS Immunol Med Microbiol (1999) 1.16
Bone marrow transplantation for severe aplastic anaemia. A review of the Westminster experience of 24 cases. Clin Lab Haematol (1983) 1.14
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma. Br J Cancer (1976) 1.06
Conservative excision and radiotherapy for early breast cancer--an acceptable alternative? Clin Oncol (1984) 1.05
Sun beds and melanoma. Br Med J (Clin Res Ed) (1983) 1.04
Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys (1978) 0.98
Use of vaccinia virus in the treatment of metastatic malignant melanoma. Br Med J (1970) 0.97
Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159. Cancer (1974) 0.93
Prophylactic lung irradiation in the treatment of osteogenic sarcoma. Clin Radiol (1978) 0.93
In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines. Eur J Cancer (1997) 0.92
Serum S100beta protein as a marker of disease activity in patients with malignant melanoma. Med Oncol (2001) 0.90
Treatment of prostatic cancer. Br Med J (Clin Res Ed) (1988) 0.90
Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine. Am J Med (1989) 0.88
Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome. J Trauma (1984) 0.87
Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre. Int J STD AIDS (1998) 0.86
An analysis of 40 cases treated by total thoracic irradiation. Clin Radiol (1969) 0.86
Hodgkin's disease. A clinico-pathological study of 250 cases with a 5-year follow-up. Br J Cancer (1973) 0.85
The primary management of breast cancer: is breast conservation feasible for all patients? Ann R Coll Surg Engl (1989) 0.85
A survey of the treatment of 200 cases of basal cell carcinoma (1959-1966 inclusive). Br J Dermatol (1974) 0.84
Insulin abuse by a drug addict. Br Med J (1972) 0.84
Oxaliplatin is active in vitro against human melanoma cell lines: comparison with cisplatin and carboplatin. Anticancer Drugs (2000) 0.83
Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann Clin Biochem (1991) 0.83
Loss of charged versus neutral heme from gaseous holomyoglobin ions. Rapid Commun Mass Spectrom (2001) 0.83
Successful bone marrow transplant for Fanconi's anaemia. Br Med J (1977) 0.83
Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study. Clin Oncol (R Coll Radiol) (1993) 0.82
Somatostatin and somatostatin analogues in oncology. Cancer Treat Rev (1989) 0.82
Bronchopulmonary Kaposi's sarcoma in 106 HIV-1 infected patients. Int J STD AIDS (1998) 0.81
Vindesine as a single agent in the treatment of advanced malignant melanoma. Cancer Chemother Pharmacol (1979) 0.81
Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma. Melanoma Res (1999) 0.81
Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. Eur J Cancer (1999) 0.81
The carcinoid syndrome and multiple hormone secretion associated with a carcinoid tumour of the uterine cervix. Case report. Br J Obstet Gynaecol (1986) 0.81
Cutaneous melanoma-associated retinopathy. Ophthalmology (1994) 0.81
Bone marrow transplantation for acute lymphoblastic leukaemia. Br J Haematol (1982) 0.80
Evaluation of human lymphoblastoid interferon in advanced malignant melanoma. Cancer (1983) 0.80
Prolonged survival in disseminated seminoma treated to aplasia by wide field X--radiotherapy and phenylalanine mustine with autologous bone marrow cell transfusion cover. Clin Oncol (1975) 0.80
Advanced ovarian carcinoma: response to the agonist D-Trp-6-LHRH. Cancer Treat Rep (1985) 0.80
Effect of ambulatory blood pressure monitoring on the diagnosis and cost of treatment for mild hypertension. Am Heart J (1988) 0.80
Metastasis to the penis from malignant melanoma: case report and review of the literature. Clin Oncol (R Coll Radiol) (1992) 0.79
Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer. Br Med J (Clin Res Ed) (1988) 0.79
Agranulocytosis in breast-cancer patients treated with levamisole. Lancet (1978) 0.79
The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers. Melanoma Res (2002) 0.79
Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma. Cancer (1979) 0.79
Sentinel-lymph-node biopsy. N Engl J Med (1999) 0.79
Legionnaires' disease in Port Elizabeth. S Afr Med J (1980) 0.79
Psychoactive drugs and the creative urge. Lancet (1980) 0.78
Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas. Cancer (1978) 0.78
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy. Br Med J (Clin Res Ed) (1984) 0.78
Severe malnutrition associated with alpha-heavy chain disease: response to tetracycline and intensive nutritional support. Am J Gastroenterol (1988) 0.78
Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules. Biomed Pharmacother (1988) 0.78
Epidermoid anal cancer in HIV infected patients. Clin Oncol (R Coll Radiol) (1996) 0.77
Uncontrolled local recurrence after treatment of breast cancer with breast conservation. Cancer (1989) 0.77
Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines. J Cancer Res Clin Oncol (1992) 0.77
In vitro cytotoxicity of norviburtinal and isopinnatal from Kigelia pinnata against cancer cell lines. Planta Med (2000) 0.77
The combination of paclitaxel with cisplatin exhibits antagonism in vitro against human melanoma. Anticancer Drugs (1996) 0.77
Split course radiation in inoperable carcinoma of the bronchus. Eur J Cancer (1979) 0.77
Novel assays for the detection of botulinum toxins in foods. Dev Biol Stand (1999) 0.76
Nocturnal dosage regimen of sucralfate in maintenance treatment of gastric ulcer. Am J Med (1987) 0.76
Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia. Helicobacter (2000) 0.76
Overexpression of HER-2 in thick melanoma. Melanoma Res (2002) 0.76
Therapeutic response to somatostatin analogue, BIM 23014, in metastatic prostatic cancer. Clin Exp Metastasis (1992) 0.76
Malignant melanoma co-existing with sarcoidosis: implications for prognosis and management. Melanoma Res (1996) 0.76
Update results of vindesine as a single agent in the therapy of advanced malignant melanoma. Cancer Treat Rev (1980) 0.75
Adjuvant interferon alfa-2b for high-risk melanoma. J Clin Oncol (1996) 0.75
Experience in the treatment of carcinoma of the cervix using a rotational technique. Br J Cancer (1974) 0.75
Adjuvant therapy of melanoma. Lancet (1998) 0.75
Prognostic factors in therapeutic lymphadenectomy in melanoma. Melanoma Res (2001) 0.75
Effect of splenic irradiation on circulating colony-forming cells in chronic granulocytic leukaemia. Br Med J (1977) 0.75
The Clinical Application of Bone Marrow Grafting. Br J Cancer (1962) 0.75
Adjuvant interferon in melanoma. Lancet (1994) 0.75
Pharmaceuticals from plants. Lancet (1994) 0.75
Salvage mastectomy after failed breast-conserving therapy for carcinoma of the breast. Ann R Coll Surg Engl (1991) 0.75
Excision of a clival and upper cervical pheochromocytoma by an extended maxillotomy approach: a case report. Skull Base Surg (1993) 0.75
Regarding Stockdale et al. IJROBP 35(4):851-857; 1996. Int J Radiat Oncol Biol Phys (1996) 0.75
Dissection of regional lymph nodes in cutaneous melanoma. Lancet (1998) 0.75
Responses of liver metastases to radiotherapy and razoxane. J R Soc Med (1992) 0.75
Paraneoplastic eosinophilia in malignant melanoma. J R Soc Med (1993) 0.75
Management of advanced prostatic cancer. Lancet (1989) 0.75